Search
for
Sort by
Research 601–630 of 1000+
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort
- Ameliorative Impact of High Inositol Diet on the Insulin Resistance and Metabolite Hormones among Women with Polycystic Ovary Syndrome
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- PROTACs: A novel strategy for cancer drug discovery and development
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- A new target for squamous cell skin cancer?
- Amphiregulin in Fibrotic Diseases and Cancer
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Biomedical Applications of Bee Venom: A Natural Approach to Cancer, Infections, and Inflammatory Diseases
- Cancer-Related Alopecia Risk and Treatment
- Heavy metals in biological samples of cancer patients: a systematic literature review
- Present Chemotherapy Induced Alopecia and Research in Future
- Clinical applications of antiandrogens
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- β‐Sitosterol—Dietary sources and role in cancer and diabetes management
- Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
- Ganoderma lucidum extract attenuates corticotropin-releasing hormone induced cellular senescence in human hair follicle cells
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Epithelial Integrity Is Maintained by a Matriptase-Dependent Proteolytic Pathway
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Prostate Carcinoma, what would be the best to do ?
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer